Lei Bao

Dr. Lei Bao


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YDY. Sangeeta Devi
Y. Sangeeta Devi
ASAnita M. Seibold
Anita M. Seibold
ASAurora Shehu
Aurora Shehu
EMEvelyn Maizels
Evelyn Maizels
JHJulia Halperin
Julia Halperin
GGGeula Gibori
Geula Gibori
Prolactin (PRL) is essential for normal reproduction and signals through two types of receptors, the short (PRL-RS) and long (PRL-RL) form. We have previously shown that transgenic mice expressing only PRL-RS (PRLR(-/-)RS) display abnormal follicular development and premature ovarian failure. Here, we report that MAPK, essential for normal follicular development, is critically inhibited by PRL in reproductive tissues of PRLR(-/-)RS mice. Consequently, the phosphorylation of MAPK downstream targets are also markedly inhibited by PRL without affecting immediate upstream kinases, suggesting involvement of MAPK specific phosphatase(s) in this inhibition. Similar results are obtained in a PRL-responsive ovary-derived cell line (GG-CL) that expresses only PRL-RS. However, we found the expression/activation of several known MAPK phosphatases not to be affected by PRL, suggesting a role of unidentified phosphatase(s). We detected a 27-kDa protein that binds to the intracellular domain of PRL-RS and identified it as dual specific phosphatase DUPD1. PRL does not induce expression of DUDP1 but represses its phosphorylation on Thr-155. We also show a physical association of this phosphatase with ERK1/2 and p38 MAPK. Using an in vitro phosphatase assay and overexpression studies, we established that DUPD1 is a MAPK phosphatase. Dual specific phosphatase inhibitors as well as siRNA to DUPD1, completely prevent PRL-mediated MAPK inhibition in ovarian cells. Our results strongly suggest that deactivation of MAPK by PRL/PRL-RS contributes to the severe ovarian defect in PRLR(-/-)RS mice and demonstrate the novel association of PRL-RS with DUPD1 and a role for this phosphatase in MAPK deactivation.

1 June 2016 in Journal of Interferon & Cytokine Research
Verified
Journal Article
Closed access
LBLei Bao
Lei Bao
JAJaime B. Alexander
Jaime B. Alexander
HZHuayi Zhang
Huayi Zhang
KSKui Shen
Kui Shen
LCLawrence S. Chan
Lawrence S. Chan
Skin barrier defects play an important role in atopic dermatitis (AD). Involucrin, an important barrier protein suppressed in human AD, is downregulated by interleukin-4 (IL-4). However, the molecular mechanism for IL-4 downregulation of involucrin has not been delineated, and especially how Stat6, a transcriptional activator, represses involucrin expression is unknown. Since Stats usually recruit p300/CBP in the general transcription machinery of their target genes and involucrin expression also involves p300/CBP, we hypothesize that Stat6 activated by IL-4 may sequestrate p300/CBP from the involucrin transcription complex, thus suppressing involucrin expression in keratinocytes. Using IL-4 transgenic mice, an AD mouse model, we find that involucrin expression is similarly downregulated as in human AD. In HaCat cells, the Jak inhibitor and dominant negative studies indicate that the Jaks-Stat6 pathway is involved in IL-4 downregulation of involucrin. Next, we transfected HaCat cells with an involucrin promoter–luciferase construct and then treated them with IL-4. IL-4 greatly suppresses the promoter activity, which is totally abolished by cotransfecting the CREB-binding protein (CBP) expression vector, indicating that IL-4 cannot downregulate involucrin in the presence of excess CBP. Finally, chromatin immunoprecipitation assay demonstrates that IL-4 decreases CBP binding to the involucrin transcription complex. For the first time, we defined a molecular mechanism for IL-4 downregulation of involucrin in keratinocytes, which may play an important role in the pathogenesis of AD.

1 February 2016 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
LBLei Bao
Lei Bao
HZHuayi Zhang
Huayi Zhang
GMGirish C. Mohan
Girish C. Mohan
KSKui Shen
Kui Shen
LCLawrence S. Chan
Lawrence S. Chan

21 September 2018 in Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
LBLei Bao
Lei Bao
CCCecilia Chau
Cecilia Chau
JBJeremy Bao
Jeremy Bao
MTMaria M. Tsoukas
Maria M. Tsoukas
LCLawrence S. Chan
Lawrence S. Chan

15 June 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
LBLei Bao
Lei Bao
BWBethany Perez White
Bethany Perez White
RCRachel C. Chang
Rachel C. Chang
JLJing Li
Jing Li
KVKatrien Vanderheyden
Katrien Vanderheyden
KAkyle amber
kyle amber

12 January 2021 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
LBLei Bao
Lei Bao
CCCecilia S. Chau
Cecilia S. Chau
ZLZhengdeng Lei
Zhengdeng Lei
HHHong Hu
Hong Hu
ACAngelina G. Chan
Angelina G. Chan
MTMaria M. Tsoukas
Maria M. Tsoukas